title: Time-course proteome analysis reveals the dynamic response of Cryptococcus gattii cells to fluconazole.
abstract: Cryptococcus gattii is an encapsulated fungus capable of causing fatal disease in immunocompetent humans and animals. As current antifungal therapies are few and limited in efficacy, and resistance is an emerging issue, the development of new treatment strategies is urgently required. The current study undertook a time-course analysis of the proteome of C. gattii during treatment with fluconazole (FLC), which is used widely in prophylactic and maintenance therapies. The aims were to analyze the overall cellular response to FLC, and to find fungal proteins involved in this response that might be useful targets in therapies that augment the antifungal activity of FLC. During FLC treatment, an increase in stress response, ATP synthesis and mitochondrial respiratory chain proteins, and a decrease in most ribosomal proteins was observed, suggesting that ATP-dependent efflux pumps had been initiated for survival and that the maintenance of ribosome synthesis was differentially expressed. Two proteins involved in fungal specific pathways were responsive to FLC. An integrative network analysis revealed co-ordinated processes involved in drug response, and highlighted hubs in the network representing essential proteins that are required for cell viability. This work demonstrates the dynamic cellular response of a typical susceptible isolate of C. gattii to FLC, and identified a number of proteins and pathways that could be targeted to augment the activity of FLC.
authors.affiliation: School of Molecular Bioscience, University of Sydney, Sydney, New South Wales, Australia.
authors.forename: Hin Siong
authors.initials: HS
authors.lastname: Chong
authors.forename: Leona
authors.initials: L
authors.lastname: Campbell
authors.forename: Matthew P
authors.initials: MP
authors.lastname: Padula
authors.forename: Cameron
authors.initials: C
authors.lastname: Hill
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Harry
authors.forename: Simone S
authors.initials: SS
authors.lastname: Li
authors.forename: Marc R
authors.initials: MR
authors.lastname: Wilkins
authors.forename: Ben
authors.initials: B
authors.lastname: Herbert
authors.forename: Dee
authors.initials: D
authors.lastname: Carter
mesh_terms: D000935:Antifungal Agents / Q000494:pharmacology; D056285:Cryptococcus gattii / Q000166:cytology* / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D015725:Fluconazole / Q000494:pharmacology*; D005656:Fungal Proteins / Q000378:metabolism; D060066:Protein Interaction Maps / Q000187:drug effects; D020543:Proteome / Q000378:metabolism*; D040901:Proteomics / Q000379:methods*; D013997:Time Factors
chemical_list: D000935:Antifungal Agents; D005656:Fungal Proteins; D020543:Proteome; D015725:Fluconazole